孕前糖尿病孕妇基线蛋白尿对围产结局的影响
这项回顾性队列研究纳入594例孕前糖尿病、孕20周前24小时尿蛋白<500 mg/d的单胎活产孕妇,按蛋白尿水平分组分析。结果显示蛋白尿>300 mg/d与早产<37周、重度子痫前期及出生体重<第10百分位显著相关。
要点
- 孕前糖尿病孕妇24小时尿蛋白>300 mg/d与早产<37周显著相关(P=.003)。
- 蛋白尿>300 mg/d与重度子痫前期显著相关(P=.002)。
- 蛋白尿>300 mg/d与出生体重<第10百分位显著相关(P=.048)。
核心结论
- 在当代孕前糖尿病孕妇队列中,24小时尿蛋白>300 mg/d与早产<37周、重度子痫前期及出生体重<第10百分位相关。
研究设计与样本
- 回顾性队列研究,纳入2009至2016年594例孕前糖尿病、孕20周前24小时尿蛋白<500 mg/d、分娩非畸形单胎活产儿的孕妇。
主要发现
- 按尿蛋白50-100、101-200、201-300、301-499 mg/d分组,重度子痫前期(趋势P=.02)、早产<37周(趋势P<.001)和出生体重<第10百分位(趋势P=.02)随蛋白尿增加而显著增加。
- 以300 mg/d为界分组,>300 mg/d组早产<37周(P=.003)、重度子痫前期(P=.002)、出生体重<第10百分位(P=.048)显著相关。
关键数值与推荐
- 24小时尿蛋白>300 mg/d为本文分析阈值,与早产<37周(P=.003)、重度子痫前期(P=.002)、出生体重<第10百分位(P=.048)相关。
临床怎么用
- 对孕前糖尿病孕妇,孕20周前24小时尿蛋白>300 mg/d可提示早产、重度子痫前期和小于胎龄儿风险升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidence of diabetes in pregnancy has increased dramatically with the rising rates of obesity. Because there are a number of recognized adverse maternal and fetal outcomes associated with diabetes, there have been several attempts to classify this disorder for perinatal risk stratification. One of the first classification systems for pregnancy was developed by White nearly 70 years ago. More recently, efforts to stratify diabetic disease severity according to vasculopathy have been adopted. Regardless of classification system, vasculopathy-associated effects have been associated with worsening pregnancy outcomes. Defining vasculopathy within an organ system, however, has not been consistent. For example, definitions of diabetic kidney disease differ from the previously used threshold of ≥500 mg/d by White for pregnancy to varying thresholds of albuminuria by the American Diabetes Association. OBJECTIVE: To evaluate a proteinuria threshold that was a relevant determinant of perinatal risk in a cohort of women with type 2 diabetes. MATERIALS AND METHODS: This was a retrospective cohort study of women with pregestational diabetes delivered of nonanomalous, singleton, liveborn infants. All women were assessed for baseline maternal disease burden with a 24-hour proteinuria quantification performed before 20 weeks' gestation. Women with <500 mg/d on 24-hour urine collections were included. Perinatal outcomes were analyzed according to the following protein excretion values: 50-100, 101-200, 201-300, and 301-499 mg/d. Based on trends noted in these results and using the prior definition of the American Diabetes Association of 300 mg/d of albumin for diabetic kidney disease, women were then analyzed according to 24-hour urine collections of ≤300 or >300 mg/d. RESULTS: Between 2009 and 2016, a total of 594 women with pregestational diabetes were found to meet study criteria. When analyzed according to protein excretion values 50-100, 101-200, 201-300, and 301-499 mg/d, there were no differences in maternal demographics. The rate of preeclampsia with severe features (P for trend = .02), preterm birth at <37 weeks (P for trend <.001), and birthweight <10th percentile (P for trend = .02) were significantly associated with increasing proteinuria excretion, with the highest rates in the >300 mg/d group. Perinatal outcomes were then examined in the context of 24-hour urine protein excretion values of ≤300 or >300 mg/d, with no differences in maternal demographics. Protein excretion values >300 mg/d were significantly associated with preterm birth <37 weeks (P = .003), preeclampsia with severe features (P = .002), and birthweight <10th percentile (P = .048). CONCLUSION: White's classification in 1949 was developed to stratify perinatal risks based on maternal disease burden, and it was found that urinary protein excretion of >500 mg/d was associated with adverse pregnancy outcomes. In a contemporary cohort of pregnant women, proteinuria >300 mg/d was associated with preterm birth, preeclampsia with severe features, and birthweight <10th percentile.
引用
- Ambia AM, Seasely AR, Macias DA, et al. The impact of baseline proteinuria in pregnant women with pregestational diabetes mellitus. Am J Obstet Gynecol MFM. 2019. PMID: 33345986. doi:10.1016/j.ajogmf.2019.100072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。